Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorJukka Putaala
About this trial
The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
Eligibility criteria
Qualifiers
Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
Age ≥40 years
Pre-existing or newly diagnosed hypertension
Informed consent from the patient or legal representative
Disqualifiers
Known high-risk source of cardioembolism
Known indication for anticoagulation
Contraindication for anticoagulation
Pacemaker
Trial design
Treatments tested in this trial
- ECG monitoring for 3 weeks
- Self-monitoring of BP and self-titration of antihypertensive medication
Treatment groups
405 Participants
are divided into 2 treatment groupsSponsors and collaborators
Jukka Putaala
Lead sponsor
Hospital District of Helsinki and Uusimaa
Sponsor institution
Source ClinicalTrials.gov